Amedisys Inc. (AMED)

73.95
0.65 0.87
NASDAQ : Health Services
Prev Close 74.60
Open 75.02
Day Low/High 73.42 / 75.25
52 Wk Low/High 45.60 / 75.53
Volume 193.97K
Avg Volume 251.00K
Exchange NASDAQ
Shares Outstanding 34.06M
Market Cap 2.45B
EPS 0.90
P/E Ratio 60.50
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMED, BCOV, CLS, DWSN, EDR, EQC, IFF, ONDK, PAGP, PKE, PTR, SJI, SRE, SWM, TRMB, TWIN Downgrades: ANDE, CBT, COLL, FLEX, GPK, GSM, HI, NAP, NTLA, RGS, UONE, UONEK Initiations: ELVT, SNDR Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOI, ATSG, CKH, CRM, DDS, EQBK, FSTR, GNK, NEWM, OAS, RDC, RRC, TCMD, UHS, WTW Downgrades: AHGP, AMED, AXE, CTRE, CULP, DOC, EMKR, GLW, HABT, IT, KBR, RP, SGEN, SPOK, SWM, TACO, UGP, UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Amedisys Reports Fourth Quarter And Year End 2017 Financial Results

Amedisys Reports Fourth Quarter And Year End 2017 Financial Results

Issues 2018 Guidance

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."

Short Interest Moves 12% Lower For AMED

Short Interest Moves 12% Lower For AMED

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 350,029 share decrease in total short interest for Amedisys, Inc. , to 2,541,688, a decrease of 12.10% since 10/31/2017.

AMED Crosses Above Average Analyst Target

AMED Crosses Above Average Analyst Target

In recent trading, shares of Amedisys, Inc. have crossed above the average analyst 12-month target price of $57.25, changing hands for $58.49/share.

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

158 Amedisys Home Health Care Centers Recognized

Short Interest In Amedisys Drops 16.8%

Short Interest In Amedisys Drops 16.8%

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 553,082 share decrease in total short interest for Amedisys, Inc. , to 2,731,061, a decrease of 16.84% since 07/14/2017.

TheStreet Quant Rating: A- (Buy)